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OBJECTIVE—Although patients with diabetes suffer from in-
creased infections and a higher incidence of cancer due to
impaired immune function, details on diabetes-induced decrease
in immunity are lacking. We assessed how immune-mediating
peripheral blood mononuclear cells (PBMCs) are affected in
diabetes.
RESEARCH DESIGN AND METHODS—From 33 patients
with type 2 diabetes and 28 healthy volunteers, we obtained
PBMCs and investigated their susceptibility to apoptosis and
functional alteration.
RESULTS—In a subpopulation of PBMCs, monocytes derived
from patients with diabetes were more susceptible to apoptosis
than monocytes from healthy volunteers. Monocytes from pa-
tients with diabetes had decreased phagocytotic activity and
were less responsive to Toll-like receptor (TLR) ligands, al-
though the expression of TLRs did not differ signiﬁcantly be-
tween the two groups. Furthermore, monocytes from patients
with diabetes had a distinctly different gene expression proﬁle
compared with monocytes from normal volunteers as assessed
with DNA microarray analysis. Speciﬁcally, quantitative real-time
detection PCR measurements showed an elevated expression of
the markers of endoplasmic reticulum (ER) stress in diabetic
monocytes, and electron microscopic examination of monocytes
revealed morphologic alterations in the ER of cells derived from
patients with diabetes. Consistently, the ER stress inducer tuni-
camycin increased apoptosis of otherwise healthy monocytes
and attenuated the proinﬂammatory responses to TLR ligands.
CONCLUSIONS—These data suggest that monocytes comprise
a substantially impaired subpopulation of PBMCs in patients
with diabetes and that ER stress is involved in these pathologic
changes mechanistically. This implies that the affected mono-
cytes should be investigated further to better understand diabetic
immunity. Diabetes 59:634–643, 2010
T
ype 2 diabetes is the most frequent metabolic
disease and the leading cause of human morbid-
ity and mortality (1,2). Based on epidemiologic
data, patients with diabetes are immunocompro-
mised and have an increased incidence of infections in the
respiratory tract, urinary tract, and skin (3–5). The high
incidence of colorectal, breast, and pancreatic malignan-
cies in patients with diabetes is also considered to be a
consequence of diabetes-associated defects in immune
function (6,7).
Although studies on immune cells and circulating cyto-
kines have shed some light on this diabetic immunologic
phenomenon, conﬂicting results have been reported and
do not adequately explain the perturbed immune function
in patients with diabetes. Controversial results concerning
the phagocytotic activity of polymorphonuclear neutro-
phils and monocytes are in part due to differences in the
patients themselves, insufﬁcient numbers in the study
populations, or inconsistencies in the collection of the
cell populations under investigation (8–11). Therefore,
further studies are needed to explain the decreased im-
mune function of patients with diabetes.
We previously investigated the gene expression signa-
tures of peripheral blood mononuclear cells (PBMCs) in
patients with diabetes and observed transcriptional ex-
pression features that were distinct from those of healthy
volunteers (12). Apoptosis-related genes were upregulated
in the PBMCs of patients with diabetes. Based on this
result, we investigated apoptotic activity and immunologic
function in PBMCs from patients with type 2 diabetes.
We observed that the CD14
 monocyte fraction was the
most affected subpopulation of PBMCs from these pa-
tients; these cells were especially vulnerable to apoptosis
compared with other cell subpopulations. We also found
that CD14
 monocytes demonstrated attenuated phagocy-
totic activity and deﬁcient Toll-like receptor (TLR) signal-
ing, both of which are important for innate immunity
(13,14). Transcriptional analysis and electron microscopic
examination of monocytes from patients with diabetes
showed evidence of endoplasmic reticulum (ER) stress,
which may underlie the functional defects in these cells.
Collectively, the data presented herein show that CD14

monocytes are a vulnerable cell population under ER
stress in these patients that could contribute to decreases
in immune function in diabetes.
RESEARCH DESIGN AND METHODS
Thirty-three patients with type 2 diabetes (male/female, 15/18; age 62.0  8.6
years; A1C 9.2  2.0%) and 28 healthy volunteers (male/female, 15/13; age
58.2  10.2 years; A1C 5.4  0.7%) were enrolled consecutively for the
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of their clinical parameters, except for the fasting plasma glucose and A1C
levels. The patients with diabetes (n  16) from whom adequate numbers of
monocytes were obtained were enrolled for additional experiments along with
17 other patients with diabetes (male/female, 8/9; age 60.5  7.2 years; A1C
8.8  1.8%) whose clinical proﬁles ﬁt the diabetic proﬁle (Table 1). Informed
consent for this study was obtained from all subjects. The experimental
protocol was carried out in accordance with the Declaration of Helsinki.
Isolation of subpopulations of PBMCs and ﬂow cytometric analysis.
PBMCs were freshly isolated from heparinized venous blood using Ficoll-
Hypaque (Sigma-Aldrich, St. Louis, MO) as previously described (12). CD4

T-cell and CD14
 monocyte subpopulations were isolated using a magnetic
cell sorting system in accordance with the manufacturer’s protocol (Miltenyi
Biotec, Bergisch Gladbach, Germany). Isolated cells were puriﬁed by 90% as
measured by ﬂow cytometric analysis using FACSCalibur ﬂow cytometer (BD
Biosciences, San Jose, CA). To assess the expression of TLRs on monocytes,
PBMCs were incubated with phosphatidylethanolamine (PE)-labeled anti-
TLR2, -TLR3, or -TLR4 (eBioscience, San Diego, CA) and ﬂuorescein isothio-
cyanate (FITC)-labeled anti-CD14 antibodies (BD Biosciences) and analyzed
by ﬂow cytometry. Data were analyzed using CELLQuest Software (BD
Biosciences).
Quantitative real-time detection PCR. Real-time detection (RTD)-PCR
was performed as previously described (15). Brieﬂy, total RNA obtained from
cells using a MicroRNA isolation kit (Stratagene, La Jolla, CA) was reverse-
transcribed using 1 g oligo (dT) primer and Super Script II Reverse
transcriptase (Invitrogen, Carlsbad, CA). The relative quantities of mRNA
expression were analyzed by RTD-PCR using ABI PRISM 7900 HT Sequence
Detection System (Applied Biosystems, Foster City, CA). All primer pairs and
probes were obtained from the TaqMan assay reagents library. Expression
levels of genes were calculated with the 2
Ct method using either -actin or
GAPDH as internal control genes.
Apoptotic cell detection assay. Freshly isolated PBMCs were incubated
with AIM-V (Invitrogen) serum-free culture media containing 5 or 30 mmol/l
glucose at 37°C with 5% CO2 for up to 24 h. The cells were incubated with
FITC-labeled anti-CD4, -CD14, or -CD56 antibodies (BD Biosciences) and with
PE-labeled annexin-V and 7-amino-actinomycin D (7-AAD) (BD Biosciences)
in PBS containing 2% BSA (Sigma-Aldrich). Apoptotic cells were determined
by ﬂow cytometry as the fraction of cells labeled with annexin-V that were
7-AAD negative. At least 10,000 cells per sample were analyzed.
Phagocytosis assay. Phagocytotic activity was assessed using a Phagotest
Kit (Orpegen Pharma, Heidelberg, Germany) and FITC-labeled opsonized
Escherichia coli in accordance with the manufacturer’s protocol. Brieﬂy,
heparinized whole blood obtained from the 33 patients with diabetes and 28
healthy volunteers was incubated with FITC-labeled E. coli for 10 min at 37°C.
After removing the erythrocytes, the remaining cells were incubated with
propidium iodide to detect viable leukocytes by ﬂow cytometry. Monocyte
populations were assessed based on cellular granularity and size as side
scatter and forward scatter, respectively, and FITC-positive cells were as-
sessed as monocytes with phagocytosed FITC-labeled E. coli.
TLR ligand stimuli and expression of proinﬂammatory cytokine genes.
Peptidoglycan (PGN; 1 g/ml) from Streptomyces sp. (Sigma-Aldrich), Poly
(I:C) (5 g/ml; Sigma-Aldrich), and lipopolysaccharide (LPS; 2 g/ml) from E.
coli (Sigma-Aldrich), which are TLR2, TLR3, and TLR4 ligands, respectively,
were added to monocytes (3 	 10
5 cells) freshly isolated from the 33 patients
and 28 healthy volunteers in AIM-V media. Before and 3 h after incubation, the
expression of tumor necrosis factor-
 (TNF-
) and interleukin-1 (IL-1) was
analyzed by RTD-PCR.
Analysis of gene expression by DNA microarray. Total RNA was obtained
from CD14
 monocytes using MicroRNA isolation kit (Stratagene), and the
mRNA was ampliﬁed twice using the Amino Allyl MessageAmp aRNA Kit
(Ambion, Austin, TX). The reference RNA sample was isolated from CD14

monocytes from a 30-year-old healthy male volunteer and ampliﬁed in the
same manner. Ampliﬁed mRNA was labeled with cyanin (Cy) 5 or Cy3
(Amersham, Buckinghamshire, U.K.). Equal amounts of the ampliﬁed mRNAs
were hybridized to an oligo-DNA chip (AceGene Human Oligo Chip 30K;
Hitachi Software Engineering, Yokohama, Japan) overnight and washed prior
to image scanning.
The ﬂuorescence intensity of each spot on the oligo-DNA chip was
obtained using cDNA Microarray Scan Array G (PerkinElmer, Wellesley, MA).
The obtained images were quantiﬁed using DNAsis array V2.6 software
(Hitachi Software Engineering). For normalization, the intensity of each spot
with oligo DNA was subtracted from that of spots without oligo DNA in the
same block. The spot was validated when the intensity was within the
intensity plus or minus a twofold range of SD within each block. By calibrating
the median as the base value, the intensities of all spots were adjusted for
normalization between Cy5 and Cy3. Hierarchic clustering of gene expression
was calibrated using the method described above using BRB Array Tools
(http://linus.nci.nih.gov/BRB-ArrayTools.html). The nonﬁltered data were log-
transformed and applied to the average linkage clustering with centered
correlation. For the functional analysis of the 813 upregulated genes, we used
GenMAPP (http://www.genmapp.org), a computer program designed for view-
ing and analyzing genome-scale data on MAPPs representing biological
pathways and any other groups of genes.
Electron microscopy. Monocytes obtained from three healthy volunteers
and three patients with diabetes were ﬁxed with 2.5% glutaraldehyde and then
postﬁxed in 1% (vol/vol) cacodylate-buffered osmium tetroxide. Samples were
dehydrated in a graded series of ethanol, transferred to propylene oxide, and
embedded in Epon-Araldite (Sigma-Aldrich). Ultrathin sections were obtained
and observed under a Hitachi H-7500 electron microscope (Hitachi High-
Technologies, Hitachinaka, Japan).
Caspase-3 assay and enzyme-linked immunosorbent assay (ELISA) of
cytokines. Monocytes from a healthy volunteer were harvested and treated
with tunicamycin (1 or 5 g/ml) in AIM-V media. Every3hu pt o1 2hafter
tunicamycin treatment, we assessed apoptosis by ﬂow cytometry as described
above. After 12 h of incubation, the expression levels of BCL-2, C/EBP
homologous protein (CHOP), and BiP (immunoglobulin heavy chain binding
protein) were assessed by RTD-PCR. The DEVD-cleaving activity of active
caspase-3 was measured using labeled Asp-Glu-Val-Asp-p-nitroanilide (DEVD-
pNA) as the substrate and the Caspase-3 Colorimetric Assay Kit (Promega,
Madison, WI) in accordance the manufacturer’s protocol. The pNA light
emission was quantiﬁed using a microtiter plate reader at a wavelength of 405
nm. In addition, we measured the production of proinﬂammatory cytokines by
RTD-PCR 6 h after treatment of monocytes (3 	 10
5 cells) with tunicamy-
cin (1 or 5 g/ml) or the TLR ligands PGN (1 g/ml), Poly (I:C) (5 g/ml),
and LPS (2 g/ml). The concentrations of TNF-
, IL-1, and IL-6 in the
culture supernatants were measured using an ELISA kit (eBioscience).
Statistical analysis. Data are expressed as means  SEM. The Mann-
Whitney U test was applied to assess the signiﬁcant differences between the
two groups. Statistical signiﬁcance was determined as P  0.05, P  0.01, and
P  0.001.
RESULTS
Increased apoptosis of CD14
 monocytes from patients
with diabetes. We ﬁrst assessed the frequency of apoptosis
in the PBMC fractions from 33 patients with diabetes and
28 nondiabetic healthy volunteers. Apoptosis of the iso-
lated cells was assessed after 3-h incubation in AIM-V
serum-free media containing 5 mmol/l glucose (physiolog-
ical concentration in blood). As shown in Fig. 1A,a
signiﬁcant difference in the frequency of apoptosis was
observed in the PBMCs isolated from patients with diabe-
tes and healthy volunteers. Adding serum to AIM-V serum-
free media did not affect the difference in apoptosis (data
TABLE 1
Characteristics of the study subjects
Diabetic
patients
(n  33)
Healthy
volunteers
(n  28) P
Age (years) 62.0  8.6 58.2  10.2 NS
Sex (male/female) 15/18 15/13 NS
BMI (kg/m
2) 23.5  4.2 23.6  4.8 NS
White blood cell counts
(ml) 4,800  1,700 5,600  1,900 NS
Lymphocytes (%) 23.5  3.5 22.7  2.5 NS
Monocytes (%) 5.2  1.6 6.1  2.3 NS
Hemoglobin (g/dl) 14.1  1.3 13.6  1.6 NS
Total cholesterol (mg/dl) 182  24 180  35 NS
Triglyceride (mg/dl) 138  37 163  33 NS
FPG (mg/dl) 185  38 86  7.4 0.001
A1C (%) 9.2  2.0 5.4  0.7 0.001
Diabetic complications
(/)* 19/14 NA
Insulin treatment (/) 10/23 NA
Data are means  SD. *Diabetic complications: nephropathy, neu-
ropathy, retinopathy, macroangiopathy. FPG, fasting plasma glucose;
NA, not applicable.
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,
CD14
, and CD56
 cells were similar in both diabetic and
healthy subjects (data not shown). CD14
 monocytes
were observed to be the major contributor to the in-
creased apoptosis measured in the PBMCs. In contrast,
apoptosis of CD4
 T-cells and CD56
 natural killer (NK)
cells was not signiﬁcantly different between the two
groups (Fig. 1A). When the incubation period in culture
media with or without serum was extended to 24 h, 20%
of the CD56
 NK cells of both patients with diabetes and
healthy volunteers were induced to undergo apoptosis.
When incubation period was extended to 5 days, 5% of
CD4
 T-cells of both patients with diabetes and healthy
volunteers were induced to undergo apoptosis; there was
no signiﬁcant difference in cell viability of CD56
 NK cells
and CD4
 T-cells between the two groups (data not
shown). BCL-2 expression of CD4
 T-cells was not differ-
ent between the two groups (data not shown). Apoptosis
of PBMC subpopulations incubated in culture media con-
taining 30 mmol/l glucose was not different from cells
incubated in 5 mmol/l glucose-containing media (data not
shown). Moreover, the susceptibility of PBMCs from pa-
tients with diabetes to apoptosis was not related to clinical
features such as vascular complications, insulin treatment,
and fasting plasma glucose concentrations (data not
shown).
However, among the 33 patients with diabetes, the
frequency of apoptotic CD14
 monocytes from those with
poor glycemic control (A1C 9.0%) was elevated com-
pared with patients with fair glycemic control (A1C
9.0%) (Fig. 1B). Furthermore, after 3-h incubation, the
increased ratio of the expression of the antiapoptotic
gene, BCL-2, was substantially lower in monocytes from
the 15 patients with A1C 9.0% compared with the 18
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FIG. 1. Monocytes contributed to the vulnerability of the PBMCs in patients with diabetes. A: PBMCs were obtained from 33 patients with diabetes and
28 healthy volunteers. Isolated PBMCs were harvested in AIM-V serum-free culture media supplemented with 5 mmol/l glucose for 3 h and incubated
with FITC-labeled anti-CD4, -CD14, or -CD56 antibodies, together with PE-labeled annexin-V to assess the frequency of apoptotic cells in each
subpopulation of PBMCs. Apoptotic cells were identiﬁed by double-staining with PE-labeled annexin-V and 7-AAD by ﬂow cytometry. The frequencies
of apoptotic cells determined as the annexin-V–positive and 7-AAD–negative population are expressed as means  SEM with statistical comparisons
for both groups. The nonparametric Mann-Whitney U test was used to calculate the P value. **P < 0.01, ***P < 0.001. The PBMCs of patients with
diabetes were more susceptible to apoptosis than those of healthy volunteers, and CD14
 monocytes were contributors. B: Among the 33 patients with
diabetes, those with poor glycemic control reﬂected as A1C >9.0% were more susceptible to apoptosis in CD14
 monocytes. Data are expressed as
means  SEM with a statistical comparison of both groups. *P < 0.05. C: Monocytes were isolated from 15 patients with A1C >9.0% and 18 patients
with A1C <9.0%. The expression of the BCL-2 gene in their monocytes before and after incubation in AIM-V serum-free media was assessed by
RTD-PCR. After 3-h incubation, the expression of BCL-2 was not upregulated in the poor glycemic control group (A1C >9.0%), compared with the fair
control group (A1C <9.0%). Data are expressed as means  SEM with statistical comparisons of both groups. *P < 0.05.
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9.0%, as assessed by RTD-PCR (Fig.
1C). These data suggest that the monocytes of patients
with diabetes are susceptible to apoptosis, especially
under conditions of poor glycemic control.
Attenuated function of monocytes from patients with
diabetes. To determine whether functional alterations
exist in monocytes isolated from the 33 patients with
diabetes, we cocultured the monocytes with FITC-labeled
E. coli and counted the number of ﬂuorescent monocytes
that phagocytosed the labeled E. coli by ﬂow cytometry.
The ratio of monocytes that phagocytosed E. coli to all
monocytes in patients with diabetes was higher than in
the healthy volunteers (Fig. 2A and B). No signiﬁcant
correlation was observed between the ratio of phagocy-
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not shown).
Next, we assessed the responsiveness of monocytes to
external pathogenic stimuli in vitro. Monocytes typically
express pattern-recognition molecules such as the TLRs
that are important for innate immunity against various
pathogens (13,14). The expression levels of TLR2, TLR3,
and TLR4 were not signiﬁcantly different between mono-
cytes from patients with diabetes and those from healthy
volunteers, as assessed by RTD-PCR (Fig. 3A) and ﬂow
cytometry (data not shown). We also found that transcrip-
tional expression of TLR signal molecules (MyD88, IRAK1,
and TRAF6 for TLR2 and TLR4 signaling and TRIF for
TLR3 signaling) was not altered in diabetic monocytes
compared with nondiabetic monocytes (data not shown).
Next, we exposed the monocytes from the patients with
diabetes and healthy volunteers to the TLR ligands, PGN
(a TLR2 ligand), Poly (I:C) (a TLR3 ligand), and LPS (a
TLR4 ligand) and measured the expression of the proin-
ﬂammatory cytokine genes, TNF-
 and IL-1. After incu-
bation, the expression of the cytokines was not
signiﬁcantly different between the groups (Fig. 3B), but the
responsiveness to PGN, Poly (I:C), and LPS was signiﬁ-
cantly attenuated in monocytes from patients with diabe-
tes compared with those from healthy volunteers as
assessed by RTD-PCR (Fig. 3C and D). These results
demonstrate that the monocytes of patients with diabetes
are functionally impaired, which implies that they could
contribute to immune deﬁciency in diabetes.
ER stress is a molecular feature of impaired monocytes.
To elucidate the molecular features of the diabetic mono-
cytes that were distinctly susceptible to apoptosis, DNA
microarray analysis was performed on CD14
 cells iso-
lated from ﬁve randomly selected patients with diabetes
and ﬁve healthy volunteers. These subjects demonstrated
clinical features near the median of all study subjects.
Unsupervised hierarchic clustering analysis was per-
formed to assess the gene expression proﬁles of mono-
cytes obtained from patients with diabetes and healthy
volunteers; 17,184 ﬁltered genes were evaluated after
excluding genes that were not expressed or those with low
expression levels that prevented their analysis in 50% of
the cases. As shown in Fig. 4A, two completely discernible
clusters formed between the patients with diabetes and
the healthy volunteers.
We identiﬁed 813 genes that were upregulated in the
monocytes from patients with diabetes compared with those
of healthy volunteers (P  0.05, Student t test). Analysis of
the biological processes concerning these genes was per-
formed using GenMAPP. The identiﬁed genes were shown to
be involved in posttranslational protein modiﬁcation systems
occurring in the Golgi apparatus or were involved in ER
stress (Table 2 and supplementary Table 1, available in an
online appendix at http://diabetes.diabetesjournals.org/
cgi/content/full/db09-0659/DC1). The elevated expression
of genes related to ER stress, such as CHOP and BiP, was
conﬁrmed using RTD-PCR; the expression of these genes
was signiﬁcantly higher in the monocytes from the 33
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volunteers (Fig. 4B). In contrast, no signiﬁcant difference
in the expression of these genes was observed in CD4

T-cells from patients with diabetes and healthy volunteers
(Fig. 4C).
Electron microscopy further conﬁrmed ER stress in the
monocytes derived from patients with diabetes. As shown
in Fig. 4D, morphologic alterations of the ER such as
corruption of concentric, continuous, and regular layer
structure and a decreased number of ribosomes on the ER
membrane were evident from the electron photomicro-
graphic images.
ER stress–induced apoptosis and attenuation of TLR
signaling in human monocytes. The results described
above indicated that the monocytes from patients with
diabetes have compromised immunologic function and
that ER stress is a distinct feature in these cells. To
determine whether ER stress could be a mechanism
underlying the observed increase in apoptosis and de-
creased responsiveness to TLR ligands, CD14
 cells iso-
lated from a healthy volunteer were treated with the ER
stress inducer, tunicamycin (1 g/ml), in AIM-V media. As
shown in Fig. 5A and B, an increased number of apoptotic
cells was observed among monocytes treated with tunica-
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diabetes were signiﬁcantly upregulated, compared with the monocytes of healthy volunteers. Data are expressed as means  SEM. *P < 0.05,
**P < 0.01. C: The expression levels of CHOP and BiP in T-cells of patients with diabetes were similar to those of healthy volunteers. Data are
expressed as means  SEM. D: Monocytes were obtained from three healthy volunteers and three patients with diabetes (healthy volunteer 1:
64-year-old man, A1C 5.7%; healthy volunteer 2: 66-year-old man, A1C 4.9%; healthy volunteer 3: 68-year-old woman, A1C 5.6%; diabetic patient
1: 56-year-old man, A1C 9.1%; diabetic patient 2: 64-year-old woman, A1C 8.2%; diabetic patient 3: 71-year-old man, A1C 10.2%) and examined
using electron microscopy. In the three patients with diabetes, the concentric, continuous, and regular layer structures of the ER were corrupted,
with fewer ribosomes on the ER membrane compared with the ER of the healthy volunteer. ER, endoplasmic reticulum; M, mitochondrion; N,
nucleus. Scale bars indicate 100 nm.
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incubation. Treatment of monocytes with a higher concen-
tration of tunicamycin (5 g/ml) induced more apoptosis
(Fig. 5A and B), and when monocytes were treated with
tunicamycin for 12 h, the activity of the proapoptotic
protease, caspase-3, signiﬁcantly increased (Fig. 5C).
Treatment with tunicamycin coordinately decreased the
expression of BCL-2 (Fig. 5D) and increased the expres-
sion of the ER stress markers, CHOP and BiP (Fig. 5E).
These results suggest that ER stress promotes apoptosis of
human monocytes.
Next, we investigated how tunicamycin-induced ER
stress affected the responsiveness of human monocytes to
TLR ligands. Treatment of monocytes with tunicamycin
for 6 h did not affect the transcriptional and translational
expression of TLR2 and TLR4 (data not shown). As shown
in Fig. 6A–C, however, the expression of the proinﬂamma-
tory cytokines TNF-
, IL-1, and IL-6 was downregulated
after stimulation with TLR2 and TLR4 ligands. Further-
more, the production of TNF-
, IL-1, and IL-6 in media
was measured by ELISA and found to decrease after
treatment of human monocytes with tunicamycin and after
stimulation with TLR2 or TLR4 ligands (Fig. 6D–F). How-
ever, tunicamycin-induced ER stress did not affect expres-
sion after treatment of monocytes with the TLR3 ligand,
Poly (I:C) (data not shown).
DISCUSSION
In the present study, we observed that PBMCs from
patients with diabetes were more susceptible to apoptosis
compared with PBMCs from healthy volunteers and that
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FIG. 5. ER stress enhanced the susceptibility of human monocytes to apoptosis. A and B: Human CD14
 monocytes obtained from a healthy
volunteer were incubated in AIM-V culture media supplemented with tunicamycin (TM) (1 or 5 g/ml). The frequency of apoptotic cells was
analyzed by ﬂow cytometry every 3 h for 12 h. More apoptotic cells were observed among monocytes treated with tunicamycin for >6ho f
incubation, compared with untreated monocytes. A: Representative scattergram of annexin-V and 7-AAD for monocytes treated with tunicamycin.
The numbers in each quadrant indicate the percentage of apoptotic cells. B: Apoptotic cells were assessed in triplicate for each condition. Data
are expressed as means  SEM. C: Caspase-3 activity in monocytes treated with tunicamycin increased signiﬁcantly at 12 h of incubation. D: The
BCL-2 expression in monocytes incubated with tunicamycin for 12 h was downregulated. E: The expression levels of the ER stress markers CHOP
and BiP in monocytes incubated with tunicamycin for 12 h were signiﬁcantly upregulated. Data are expressed as means  SEM of three
independent experiments. e, No treatment; o, treatment with tunicamycin (1 g/ml); f, treatment with tunicamycin (5 g/ml).
TABLE 2
Biological processes for upregulated genes in monocytes of
diabetic patients
Z score Permute P value
MAPP name
Golgi apparatus 3.383 0.000
Ribosomal proteins 3.691 0.002
Unfold protein binding 2.471 0.026
Intracellular protein
transport 2.310 0.029
Enzyme-linked receptor
protein signaling pathway 2.175 0.042
Nuclear receptor 2.316 0.043
Gametogenesis 1.998 0.049
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 monocytes comprised the primary PBMC subpopu-
lation undergoing apoptosis. We also found that CD14

monocytes from patients with diabetes were hyporespon-
sive to TLR ligands and that they had attenuated phago-
cytotic activity. Transcriptional analysis and electron
microscopy revealed the presence of ER stress in the
affected diabetic monocytes. Consistently, monocytes iso-
lated from nondiabetic patients showed a similar increase
in apoptosis and a weakened response to TLR ligands,
when they were treated with tunicamycin, indicating that
ER stress may be a pivotal mechanism underlying the
decreased immunologic function observed in patients with
diabetes.
As innate immune-defense mediators, monocytes are
capable of ingesting exogenous pathogens to protect the
host from infectious diseases. Previous studies have
shown that phagocytosis in diabetic neutrophils and
monocytes is attenuated (10,11). Similarly, in our study
population, monocytes from patients with diabetes were
less capable of phagocytosing E. coli pathogens compared
with monocytes derived from healthy volunteers. This
novel ﬁnding might explain, at least in part, the decrease in
immune function characteristic of patients with diabetes
(16). Nevertheless, the detailed mechanisms underlying
diabetes-induced decreases in phagocytotic activity re-
main unclear, because simple high-glucose concentration
neither affected the phagocytotic activity and TLR expres-
sion nor induced ER stress in nondiabetic monocytes in
vitro (data not shown).
The TLRs are pattern-recognition receptors that are
important for recognizing pathogens, inducing proinﬂam-
matory responses, and preventing the host from acquiring
infectious diseases (17–20). The expression of TLR2,
TLR3, and TLR4 in CD14
 monocytes was similar between
patients with diabetes and healthy volunteers. The admin-
istration of a high dose of insulin downregulates TLR
expression (21). Transformed monocyte-lineage blastoma
cells showed increased TLR expression under hyperglyce-
mic conditions in vitro (22). Type 2 diabetes is character-
ized as a state of inadequately controlled glycemia
associated with hyperinsulinemia due to peripheral insulin
resistance (1). Taken together, the TLR expression may be
affected by hyperglycemia and hyperinsulinemia in a com-
plex manner. In contrast to the previous ﬁnding that
monocytes from patients with diabetes were hypersensi-
tive to the TLR ligand, LPS (23,24), we observed that the
TNF-
 and IL-1 expression from monocytes derived from
patients with type 2 diabetes diminished after exposure to
PGN, Poly I:C, and LPS—ligands of the TLR2, TLR3, and
TLR4 receptors, respectively. These data suggest that
diabetes perturbs signaling downstream of the TLRs. In
this study, we collected CD14
 monocytes from PBMCs
via enrichment using magnetic beads; this protocol was
used to remove T-cells, NK cells, B-cells, dendritic cells,
and basophils from the PBMC mixture. This is in contrast
to the methodology used to isolate these cells in many
other studies, in which monocytes were obtained as
adherent cells in the culture dish or by a rosetting tech-
nique (25,26). CD14
 cells have been shown to be com-
posed of multiple subtypes of activated states; the
classical monocyte-isolation methods used in the other
studies might unknowingly remove the fraction of mono-
cytes that are susceptible to apoptosis (27). More than half
of the CD14
 diabetic monocytes isolated in this study
were dead after 12-h incubation, even in media containing
physiological concentration of glucose (data not shown).
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FIG. 6. Expression of proinﬂammatory cytokines in response to TLR ligand stimuli decreased in human monocytes treated with tunicamycin
(TM). Isolated human CD14
 monocytes were incubated in AIM-V culture media with tunicamycin (1 or 5 g/ml) and stimulated using TLR
ligands, PGN, and LPS for 6 h. A–C: RTD-PCR analysis showed that the expression of TNF- (A), IL-1 (B), and IL-6 (C) was downregulated in
human CD14
 monocytes treated with tunicamycin, especially at the higher concentration (5 g/ml). D–F: ELISA showed that the production of
TNF- (D), IL-1 (E), and IL-6 (F) in culture media decreased in human monocytes treated with tunicamycin, especially at the higher
concentration (5 g/ml). Data are expressed as means  SEM of four independent experiments. e, No treatment; o, treatment with tunicamycin
(1 g/ml); f, treatment with tunicamycin (5 g/ml).
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ness to ligands in diabetic monocytes suggest that initial
immune responses that are normally triggered by viruses,
bacteria, and parasites could be impaired in diabetes,
which is consistent with epidemiologic data showing a
high incidence of infection in patients with diabetes (3–5).
Gene expression and electron microscopic analysis of
monocytes derived from patients with diabetes showed
active signatures of ER stress; this is important because
ER is an organelle essential for the proper folding and
glycosylation of proteins after protein synthesis (28).
When cells are under ER stress, protein kinase R–like ER
kinase, inositol-requiring enzyme 1, and activating tran-
scription factor 6 are activated and function in the adap-
tation to stress, proper folding of proteins, and removal of
harmful unfolded proteins, respectively (29,30). However,
prolonged ER stress leads to apoptotic cell death, which is
mediated by CHOP (31). CHOP is a crucial and speciﬁc
molecule for ER stress–induced apoptosis and alters the
transcription of the BCL-2 gene family members (32). The
current study showed that diabetic monocytes had in-
creased levels of ER stress–related apoptotic molecules.
Moreover, nondiabetic monocytes treated with tunicamy-
cin, an ER stress inducer, underwent apoptosis in a
manner similar to monocytes derived from patients with
diabetes. From these data, we conclude that ER stress
contributes to the susceptibility of diabetic monocytes to
apoptosis.
We also observed that tunicamycin-induced ER stress
diminished TLR2 and TLR4 signaling without altering
expression of TLRs. Tunicamycin induces ER stress by
disturbing N-linked glycosylation (33), and previous re-
ports suggest that perturbations in this glycosylation at-
tenuate TLR2 and TLR4 signaling in vitro (34,35). Hence,
these data collectively indicate that ER stress may under-
lie decreases in TLR2 and TLR4 signaling and affect
immune function in patients with diabetes.
TLR3 signaling is different from the other TLR signaling
pathway; for example, it is independent of MyD88. TLR2
and TLR4 are expressed on the cell surface, whereas TLR3
is expressed in intracellular compartments such as endo-
somes (13), and its ligands require internalization before
signaling occurs. This suggests that disturbances in TLR3
signaling in diabetic monocytes may be due to reasons
other than ER stress. Further investigations are needed to
elucidate the detailed mechanisms of attenuated TLR
signaling in monocytes from patients with diabetes.
ER stress has been shown to be a mainstay of the
diabetic condition. Its pathologic importance in diabetes is
especially important in pancreatic -cells, in which glu-
cose toxicity results in ER stress and insufﬁcient insulin
secretion (36–38). The current study suggests that mono-
cytes are yet another population of cells vulnerable to
hyperglycemia-induced ER stress and dysfunction. Never-
theless, the mechanisms that render pancreatic -cells and
monocytes vulnerable to ER stress in patients with diabe-
tes remain uncertain.
Diabetes is considered a chronic inﬂammatory disease.
Activated macrophages that produce proinﬂammatory cy-
tokines such as TNF-
, IL-1, and IL-6 are thought to
contribute to insulin resistance in muscle and adipose
tissues (39,40). Furthermore, the atherosclerotic compli-
cations in patients with diabetes have a basis in inﬂamma-
tion; local inﬂammatory foci in atherosclerotic lesions are
commonly composed of foam cells derived from activated
macrophages (41,42). Further studies are needed to deter-
mine whether different subpopulations of monocyte-de-
rived cells, for example, systemically circulating and
locally residing inﬂammatory cells, are susceptible to
hyperglycemia-induced ER stress and dysfunction.
In conclusion, our ﬁndings show that CD14
 monocytes
are susceptible to ER stress–induced alterations in inﬂam-
matory signaling and apoptosis, which may play a role in
the decreased immune function observed in patients with
diabetes. Further investigations are needed to discern the
mechanisms of diabetes-induced ER stress and perturba-
tions in inﬂammatory signaling in CD14
 monocytes.
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